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Abstract
Background: Nerium oleander L. (syn. Nerium indicum Mill, Nerium odorum Aiton) belongs to the family Apocynaceae.
It is used for its anti-inflammatory, anti-diabetic, anti-cancer and hepatoprotective activities in traditional medicine.
Previous pharmacognostic studies suggested that 70 % hydro-methanolic extracts of oleander possess potent free
radical scavenging and anti-inflammatory activities, both of which are helpful against hepatotoxicity.
Methods: Hydro-methanolic extracts of oleander stem and root were evaluated for their hepatoprotective activities in
acute CCl4 intoxicated mouse through in vitro and in vivo studies. Silymarin was used as positive reference. Antioxidant
enzymes, pro-inflammatory markers and liver enzymatic and biochemical parameters were studied. The extracts were
further chemically characterized using Fourier Transform Infrared (FTIR) spectroscopy and Gas chromatography-mass
spectrometry (GC-MS).
Results: CCl4 toxicity caused fatty liver formation by increase of relative liver weight (32.53 g) compared to control
group (16.08 g). The elevated liver enzymatic and biochemical parameters due to CCl4 toxicity were considerably
normalized by the extracts treatment under both in vivo and in vitro models. Oleander stem (NOSE) and root (NORE)
extracts increased the reduced hepatic catalase activity 27.37 and 25.25 %, whereas peroxidase activity was increased
18.19 and 22.78 %, respectively. The extent of lipid peroxidation was significantly (p < 0.01) lowered 20.76 % (NOSE) and
21.12 % (NORE) compared to CCl4 group. The levels of pro-inflammatory tumor necrosis factor-α (TNF-α) was lowered
71.33 % (NOSE) and 61.60 % (NORE). Histopathological study demonstrated substantial reduction of hepatocellular
necrosis, fatty infiltration, sinusoidal dilation, bile duct proliferation, vascular congestion, leukocyte infiltration in the
silymarin and extract treated groups. Furthermore, various bioactive compounds were identified in the extracts such as
apocynin, tocopherol, squalene, vanillin, isoeugenol, amyrin, lupeol etc.
Conclusion: The present study provided convincing evidence that oleander extracts possess potent hepatoprotective
capacity which was primarily governed by its antioxidant and anti-inflammatory activities. The collegial bioactivities of
the phytochemicals may be accredited behind the hepatoprotective activity of oleander.
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Background
The liver is the largest organ of our body, contributing
about 2 % of the total body weight. The liver is associ-
ated with most of the metabolic and physiological process
including growth, immunity, nutrition, energy metabolism
and reproduction [1]. Production of different coagulation
factors, antithrombin, thrombopoietin, angiotensinogen,
insulin-like growth factor 1, albumin, catabolism of biliru-
bin and various hormones takes place in the hepatic sys-
tem. Liver performs central role in the biotransformation
and metabolism of xenobiotic compounds, which in some
case results in liver damage [2]. Though the liver possesses
tremendous regenerative capacity, but very often subclin-
ical live injury occurs due to toxic chemicals and their
metabolic intermediates. Around the globe, drug induced
hepatotoxicity has emerged as a serious medical concern
where 10 % cases of acute liver failures are associated with
idiosyncratic hepatotoxicity [3]. Drug induced hepatotox-
icity has now appeared as the leading cause behind acute
liver failure among the US patients [4]. The liver is one of
the decisive organs of the body and therefore, requires
safeguard from harmful chemicals.
Persistent exposure to xenobiotics, especially synthetic
drugs and environmental chemicals cause serious liver
damage due to its portal location in the circulation and
central role in detoxification [5, 6]. Most xenobiotics are
lipophilic in nature and thus, are poorly excreted by the
kidney. The liver performs a critical role in biotrans-
formation of such xenobiotics to more polar form in
order to facilitate their excretion [7]. Halogenated al-
kanes are organic xenobiotics which holds the potential-
ity to cause severe liver injury [2, 6]. CCl4 is a model
haloalkane which is extensively used to study the
pathophysiological implications of xenobiotic metabol-
ism and hepatoprotective potentialities of natural com-
pounds [8]. Xenobiotic mediated liver damage like CCl4
toxicity, is primarily governed by free-radical mediated
tissue injury and inflammatory damages. CCl4 cause he-
patocellular ionic imbalance, oxidative stress, transla-
tional inhibition, Ca2+ shift, mitochondrial respiratory
chain blockage and impairment of β-oxidation [9, 10].
Histopathological signs of CCl4 toxicity includes zonal
haemorrhagic necrosis, fatty infiltration, sinusoidal dila-
tion, calcification, vascular congestion, bile duct prolif-
eration and leukocyte infiltration [8].
Previously, we have demonstrated that the 70 %
hydro-methanolic extracts of oleander possess potent
antioxidant capacity [11]. The extracts also demonstrated
free radical scavenging activities against various reactive
species associated with hepatotoxicity such as hydroxyl
(OH●), superoxide (O2
●−), peroxynitrite (ONOO−), singlet
oxygen (1O2), hydrogen peroxide (H2O2) and nitric oxide
(NO), in addition to potent iron (Fe2+) chelation activities,
overload of which may lead to haemochromatic liver [12].
It is interesting to note that, a recent in vivo preliminary
study demonstrated that N. indicum leaf extract amelio-
rates haemochromatic conditions in mouse [13]. More-
over, another recent study showed that N. indicum leaf
extract attenuates CCl4 mediated hepatotoxicity in
Swiss albino mouse [14]. Simultaneously, the same
70 % hydro-methanolic extract of oleander leaf possess
anti-inflammatory activities by modulation of Th1/
Th2 cytokine balance, inhibition of cyclooxygenase,
prostaglandin E2 (PGE2) and nitric oxide levels in
mitogen induced splenic lymphocytes [15, 16]. More-
over, diverse pharmacognostic activities such as anti-
diabetic, anti-microbial, antinociceptive, neuroprotec-
tive, anti-ulcer, anti-cancer etc. of oleander extracts
and oleander derived bioactive components has also
been demonstrated previously [17].
Oleander is extensively used as herbal medicine in dif-
ferent parts of the world [17]. The pharmacognostic
studies are mostly limited to the bioactivities of its leaf
extracts. However, traditional therapies suggests exten-
sive use of oleander stem and root to cure diverse ail-
ments [17]. Therefore, the present study was initiated
to evaluate the proposed hepatoprotective potentiality
of steam and root extracts of oleander against haloalk-
ane induced hepatic injury in murine model. The study
was supported by both in vitro and in vivo experi-
ments. Further, phytochemical characterization were
carried out using FTIR and GC-MS methods to reveal
the bioactive constituents in the extracts and to correl-
ate the individual bioactivities of the phytochemicals
with the proposed hepatoprotective potentiality of ole-
ander stem and root.
Methods
Chemicals
All the chemicals were procured from Sisco Research
Laboratories Pvt. Ltd. (Mumbai, India) unless otherwise
indicated. Silymarin was obtained from Sigma-Aldrich
(USA). Fetal bovine serum (FBS), RPMI-1640, antibiotics
and EZcount™ MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide) Cell Assay Kit were pur-
chased from HiMedia Laboratories Pvt. Ltd. (Mumbai,
India). Albumin, γ-glutamyl transferase (GGT), lactate
dehydrogenase (LDH), alkaline phosphatase (ALP), bili-
rubin, protein, aspartate transaminase (AST), acid phos-
phatase (ACP), alanine transaminase (ALT), glucose,
urea and cholesterol estimation kits were obtained from
Crest Biosystems (Goa, India). TNF-α ELISA kit was
procured from Ray Bio (Georgia, United States) and
Thiobarbituric acid reactive substances (TBARS) assay
kit was purchased from Cayman chemical company
(USA). Milli-Q ultrapure water from the departmental
central facility was used in the experiments.
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Preparation of plant extract
Stem and root samples of white flowered variety of ole-
ander were collected from the garden of University of
North Bengal (26.71°N, 88.35°S), India. The plant mate-
rials were identified by senior plant taxonomist Prof.
Abhaya Prasad Das of Department of Botany, University
of North Bengal. The voucher specimen was stored at
the herbarium of Department of Botany, University of
North Bengal with an accession number of 09618.
The stem and root samples were washed properly with
double distilled water to remove any dust and foreign
materials. The samples were then chopped to 0.5 cm
pieces and shade dried at laboratory temperature
(25 °C). After 20 days, 70 % hydro-methanolic extract
of Oleander stem and root were prepared according
to the previous method [11]. A schematic representa-
tion of the extract preparation method is provided in
the Additional file 1. The lyophilized extracts were
stored at −20 °C until further use. The final yield of
oleander stem (NOSE) and root (NORE) extracts
were 11.82 and 15.22 % of dry weight (DW).
Animal maintenance
Swiss albino mice (6–8 weeks, 20–25 g) of both sex (3
male and 3 female per group) were maintained inside
cage bins (Tarson, India) with rice husk bedding in the
animal house of the Department of Zoology, University
of North Bengal at a constant 12 h photoperiod
(temperature 25 ± 2 °C; humidity 55 ± 5 %) with food
and water ad libitum. All the experiments were ap-
proved by the ethical committee, University of North
Bengal (No. 840/ac/04/CPCSEA) and conducted in ac-
cordance with the legislation for the protection of ani-
mals used for scientific purposes.
Acute toxicity study
OECD guidelines (test 423: Acute oral toxicity – Acute
toxic class method, 2002) were followed to study the
acute toxicity of the extracts [18]. Mice were divided
into eight groups (n = 6) and fasted overnight prior to
the experiment. NOSE and NORE were administered or-
ally at 250, 500, 1000 and 2000 mg/kg body weight (bw)
dose. Each groups were carefully observed at 30 min and
then 2, 4, 8, 24 and 48 h for development of any clinical
or toxicological symptoms such as tremors, convulsions,
salivation, diarrhoea, lethargy, sleep, coma and alteration
in respiratory patterns, skin colour, behaviour pattern etc.
Experimental design: in vivo
Animals were divided into 7 separate groups (n = 6) and
following treatments were done once each day for 10
consecutive days: Control group received normal saline;
CCl4 group received 1:1 (v/v) CCl4 in olive oil; Silymarin
group received 1:1 (v/v) CCl4 in olive oil and 100 mg/kg
bw silymarin; NOSE low group received 1:1 (v/v) CCl4
in olive oil and 50 mg/kg bw NOSE; NOSE high group
received 1:1 (v/v) CCl4 in olive oil and 200 mg/kg bw
NOSE; NORE low group received 1:1 (v/v) CCl4 in olive
oil and 50 mg/kg bw NORE; NOSE high group received
1:1 (v/v) CCl4 in olive oil and 200 mg/kg bw NORE.
On 11th day i.e., 24 h after the last treatment, under
anaesthesia (2 % ether), blood was collected from the
treated animals by cardiac puncture and finally the ani-
mals were sacrificed. Blood was allowed to clot for 60 min
at room temperature (25 °C) and then serum was col-
lected by centrifuging at 1000 rpm for 5 min. The straw
coloured serum was used to study liver marker enzymes.
Liver samples were collected and washed with double dis-
tilled water to remove blood and used for antioxidant en-
zymatic assays. Liver tissue required for histological study
were collected in Bouin’s solution.
Liver function test: in vivo
Serum samples from each group were used to study ACP,
albumin, globulin, glucose, ALP, bilirubin, cholesterol,
LDH, GGT, AST, ALT, total protein and urea levels using
commercially available kits (Crest Biosystems).
Estimation of peroxidase and catalase activities
Peroxidase activity in the liver samples were estimated
by measuring the oxidation of guiacol according to a
standard method [19]. Catalase activity was measured by
degradation of substrate H2O2 by catalase in the liver
tissue samples following the standard method described
by Luck [20].
Experimental design: in vitro
The in vitro hepatoprotective capacity of NOSE and
NORE were studied according to previously standard-
ized methods with minor modifications [14, 21, 22].
Briefly, seven groups of primary explant culture of mice
hepatocytes were prepared in RPMI-1640 medium (con-
taining 50 U/ml penicillin, 50 U/ml streptomycin and 50
U/ml nystatin) supplemented with 10 % FBS. After 48 h
of the culture, the following treatments were done: Con-
trol had no separate treatment; CCl4 group received
25 μl/ml CCl4; Silymarin group received 25 μl/ml CCl4
and 100 μg/ml silymarin; NOSE low group received
25 μl/ml CCl4 and 25 μg/ml NOSE; NOSE high group
received 25 μl/ml CCl4 and 100 μg/ml NOSE; NORE
low group received 25 μl/ml CCl4 and 25 μg/ml NORE
and NORE high group received 25 μl/ml CCl4 and
100 μg/ml NORE.
The plates were incubated for 2 h and then culture su-
pernatants were collected by centrifugation (5000 rpm
for 10 min).
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Liver function test: in vitro
Culture supernatants from each group were analysed for
ACP, ALP, bilirubin, LDH, AST, ALT and total protein
levels using commercially available kits (Crest Biosystems).
Measurement of lipid peroxidation
The extent of lipid peroxidation was measured in six
sets using TBARS assay kit (Cayman) according to the
manufacturer’s instructions. In brief, 100 μl serum sam-
ples of different groups were mixed with 100 μl sodium
dodecyl sulphate (SDS) solution. The tubes were placed
on boiling water bath after addition of 4 ml colour re-
agent. After 60 min incubation, the tubes were kept on
ice for 10 min to stop the reaction. Then the solutions
were centrifuged (1600 g) for 10 min at 4 °C and the ab-
sorbance of the supernatants were recorded at 340 nm.
Measurement of TNF-α
The amount of TNF-α released in culture supernatants
were measured using TNF-α ELISA kit (Ray Bio) accord-
ing to the manufacturer’s instructions. Absorbance was
immediately measured at 450 nm using Bio-Rad iMark™
microplate absorbance reader. Standard was run in par-
allel to the samples.
Measurement of inhibition of NO
Culture supernatants were used to determine the NO
level using the Griess reagent method [23] with some
modifications. Briefly, culture supernatants (60 μl) from
each group was mixed with 240 μl of Griess reagent
(1 % sulfanilamide and 0.1 % N-(1-naphthyl) ethylenedi-
amine hydrochloride in 2.5 % H3PO4) in a 96-well plate
and incubated for 20 min at room temperature. The pur-
ple azo-dye formed, was detected at 540 nm.
Measurement of cell viability
Hepatocyte necrosis results due to CCl4 toxicity.
Therefore, MTT assay was performed to measure the
protection rendered by NOSE and NORE against CCl4
mediated toxicity. Hepatocytes were cultured as de-
scribed under the in vitro experimental section. The
cell viability assay was performed in six sets using
EZcount™ MTT Cell Assay Kit (HiMedia) according to
the manufacturer’s instructions.
Histopathological studies
Liver samples were removed from the animals of the in
vivo experiments after collection of blood and were fixed
overnight in 10 % buffered formalin. The samples were
subjected to dehydration and then embedded in paraffin
blocks. Thick sections (4 μm) of the paraffin embedded
livers were cut in a microtome and then dewaxed in xy-
lene, rehydrated in a series of different grades of alcohol
and then washed with distilled water for 5 min.
Subsequently, the sections were stained with haematoxy-
lin for 40 s and counterstained with eosin for 20 s. The
sections were dehydrated in graded alcohol series and
washed in xylene. The slides were observed (100× and
400×) for signs hepatic injury using Nikon ECLIPS E200
microscope.
Fourier Transform Infrared (FTIR) spectroscopy analysis
FTIR spectrophotometry was used to identify the charac-
teristic functional groups in NOSE and NORE. Small
quantity (<10 mg) of dried extracts were taken in CaF2
vessel and placed in the sample cup of a diffuse reflectance
accessory. The IR spectrum was obtained using Shimadzu
8300 FTIR spectrophotometer at ambient temperature.
Background correction was made by taking IR spectrum
of de-ionized water as the reference in identical condition.
The sample was scanned from 400 to 4000 cm−1 for 16
times to increase the signal to noise ratio.
GC-MS analysis
NOSE and NORE were initially bi-fractionated by dis-
solving in dichloromethane and n-hexane separately. The
mixtures were centrifuged thrice (12,000 rpm) for 15 min.
The clear supernatant was used for GC-MS analysis using
Agilent 5975C GC-MS system (Agilent Technologies,
USA) attached with HP-5 ms Capillary Column (30 m ×
0.25 mm i.d. × 0.25 μm film thickness). The machine was
equipped with inert MSD triple axis mass detector condi-
tioned at ion trap 200 °C, transfer line 280 °C, electron en-
ergy 70 eV (vacuum pressure- 2.21e–0.5 torr) was used for
analysis. Helium was used as carrier gas (1 ml/min). Sam-
ple volume was 2 μl and injected in a splitless mode. The
column temperature was kept at 60 °C for 1 min followed
by 5 °C/min up to 250 °C. The major and essential com-
pounds present in samples were identified by their reten-
tion times and mass fragmentation patterns using Agilent
Chem Station Integrator and the database of National
Institute Standard and Technology (NIST) with a MS
library version 2010.
Statistical analysis
All data are reported as mean ± SD of six measurements.
Statistical analysis was performed and graphs were pre-
pared using KyPlot Data Analysis and Visualization soft-
ware version 5.0.2 (32 bit). Comparison between groups
were performed using one-way analysis of variance
(ANOVA). p < 0.05 was considered significant.
Results
Acute toxicity study
NOSE and NORE were administered to experimental
animals up to 2000 mg/kg dose for evaluation of
toxicity and selection of experimental doses. However,
up to the highest dose, no signs of mortality or
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physiological discomfort were observed in the animals.
Therefore, 1/40th (50 mg/kg) and 1/10th (200 mg/kg) of
the highest dose were selected for the in vivo hepato-
protective experiments.
Body and liver weight
Significant change (p < 0.001) in body weight were ob-
served in CCl4 and silymarin groups (Table 1). However,
unlike all other groups, final body weight was decreased
(17.07 ± 2.56 %) only in case of CCl4 group. Similarly,
compared to control, significant (p < 0.01) difference of
liver weight (5.32 ± 0.18 g) in CCl4 group was observed,
which also resulted in highest relative liver weight
(32.53 ± 3.03 g) of the same group. Interestingly, among
all groups, both the high dose groups prevented utmost
percentage body weight change. However, the relative
liver weight of all the groups were comparable, except
CCl4 group.
Liver marker enzymes and biochemical parameters (in
vivo)
Table 2 summarized the effect of CCl4 and subsequent
treatment of silymarin and oleander extracts on the
serum enzymatic and biochemical parameters in the ex-
perimental animals. The parameters were abnormally
altered due to CCl4 exposure and subsequently normal-
ized by treatments with silymarin and oleander extracts.
Among all the parameters, only the levels of protein
and albumin were lowered due to CCl4 treatment. The
percentage change in the parameters are summarized
in Additional file 2.
Estimation of hepatic anti-oxidative enzymes: catalase
and peroxidase
The activities of catalase and peroxidase enzymes in hep-
atic tissue were significantly (p < 0.001) lowered as a result
of CCl4 treatment (Fig. 1). The catalase and peroxidase ac-
tivities in the control group were 6.83 mM H2O2 con-
sumed/min/mg tissue and 12.99 Unit/mg tissue, which
were lowered respectively to 3.58 mM H2O2 consumed/
min/mg tissue and 6.32 Unit/mg tissue due to CCl4 ad-
ministration. This resulted in 47.58 and 51.34 % lowering
of antioxidant enzymatic activities, respectively. The per-
centage change in catalase activities in the silymarin,
NOSE high and NORE high groups were 58.56, 27.37 and
25.25, respectively. Similarly, the percentage change in
peroxidase levels were 46.20, 18.19 and 22.78, respectively.
Liver marker enzymes and biochemical parameters (in vitro)
The effects of silymarin and oleander extracts on the in
vitro enzymatic and biochemical parameters are summa-
rized in Table 3. The results demonstrated lowering of
the parameters as a result of CCl4 toxicity. The total
protein level was only elevated. However, the elevation
was not significant enough (p > 0.05). The percentage
change of the parameters are enlisted in Additional file 2.
Lipid peroxidation (MDA content)
The effects of CCl4 toxicity and subsequent treatment
with plant extracts on the MDA content are represented
in Fig. 2a. Initially the MDA content was elevated from
2.73 ± 0.06 μM/l in control to 5.49 ± 0.18 μM/l in CCl4
group, contributing to 2.01 fold elevation. However, the
subsequent treatments resulted in 45.53, 20.76 and
21.12 % decrease in blood MDA content respectively in
silymarin, NOSE high and NORE groups.
Cell viability
CCl4 mediated direct cellular damage (Fig. 2b) was rep-
resented by significant (p < 0.001) difference (61.92 %) in
cell viability between control and CCl4 group. How-
ever, the cell viability was improved by subsequent
treatment with silymarin (p < 0.001) and the oleander
extracts (p < 0.01). The extent of improvement of cell
viability were 106.95, 47.32 and 51.60 %, respectively
for in silymarin, NOSE high and NORE groups.
Measurement of TNF-α
The levels of TNF-α in different groups are demonstrated
in Fig. 2c. The level of TNF-α in control was 58 ±
Table 1 Changes of the body weight (g) and liver weight (g) in different experimental groups. Data represented as mean ± SD of
six observations
Initial body weight Final body weight % body weight change Liver weight Relative liver weight
Control 22.17 ± 0.70 24.23 ± 0.99* 9.26 ± 1.18▲ 4.37 ± 0.21 18.04 ± 0.13
CCl4 21.10 ± 0.34 17.49 ± 0.27*** 17.07 ± 2.56▼ 5.32 ± 0.18** 32.53 ± 3.03
Silymarin 21.64 ± 0.19 23.43 ± 0.25*** 8.29 ± 1.39▲ 4.30 ± 0.09NS 18.37 ± 0.22
NOSE low 21.71 ± 0.49 22.36 ± 0.67NS 3.96 ± 3.90▲ 4.59 ± 0.16NS 20.56 ± 1.36
NOSE high 22.25 ± 0.38 22.67 ± 0.18NS 1.89 ± 2.38▲ 4.55 ± 0.29NS 20.05 ± 1.18
NORE low 22.14 ± 0.38 22.59 ± 0.21NS 2.25 ± 2.02▲ 4.41 ± 0.16NS 19.50 ± 0.58
NORE high 22.20 ± 0.57 22.33 ± 0.46NS 1.48 ± 0.26▲ 4.24 ± 0.10NS 19.00 ± 0.52
NSp > 0.05, *p < 0.05, **p < 0.01 and ***p < 0.001. Final body weight was compared with initial body weight of corresponding group and liver weight of treated
groups were compared with liver weight of control group. ▲ represents increase and ▼ represents decrease
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20.22 pg/ml, which was 18.54 fold increased to 1075.66 ±
61.53 pg/ml due to CCl4 toxicity. However, the TNF-α
level was subsequently lowered to 43.19, 71.33 and
61.60 % in silymarin, NOSE high and NORE high groups
respectively, compared to CCl4 group. All the extract
treated groups demonstrated higher TNF-α inhibitory ac-
tivities than the silymarin group.
Inhibition of nitric oxide
CCl4 toxicity resulted in 3.22 fold increase in NO release
compared to control (Fig. 2d). However, significant (p <
0.001) lowering of NO level was observed in the treated
groups. The NO level in silymarin, NOSE high and
NORE high groups were 111.88 ± 8.60, 142.89 ± 8.72 and
161.24 ± 7.39 % respectively, when NO release of control
was considered as 100 %. This resulted in 0.34, 0.44 and
0.50 fold lowering of NO level.
Histopathological studies
The extent of liver damage caused by haloalkane toxicity
was clearly evident through the haematoxylin-eosin stain-
ing in the histopathological studies (Figs. 3 and 4). The
normal hepatic architecture in the control could be de-
scribed by presence of intact spherical nucleus, healthy
cellular architecture, well preserved hepatocellular sym-
metry, marked cellular boundaries, and clear cytoplasm.
Extensive hepatocellular damage in the CCl4 group could
be described through the presence of dilated sinusoids,
fatty infiltration and deformed cellular margins. Extensive
sings of inflammation was visible in terms of infiltration of
Table 2 Changes in the levels of various enzymatic and biochemical parameters of the serum samples of seven experimental groups.
Data represented as mean ± SD of six observations
Control CCl4 Silymarin NOSE low NOSE high NORE low NORE high
ACP (K.A.) 3.61 ± 0.31 10.94 ± 1.04*** 5.76 ± 0.43** b 10.01 ± 0.61*** d 8.75 ± 0.44*** c 9.64 ± 0.31*** d 8.55 ± 0.32*** c
ALP (K.A.) 10.86 ± 1.29 28.44 ± 1.25*** 12.93 ± 0.80NS a 24.92 ± 2.27*** d 22.21 ± 2.45** a 24.56 ± 0.95*** c 22.10 ± 1.45*** b
AST (U/ml) 65.88 ± 3.74 137.28 ± 2.95*** 74.01 ± 0.16NS a 121.27 ± 2.89*** a 99.19 ± 5.48*** b 117.93 ± 6.30*** b 110.25 ± 5.00*** b
ALT (U/ml) 42.63 ± 1.4 126.26 ± 4.88*** 53.81 ± 3.15** a 109.27 ± 4.21*** c 81.27 ± 7.66** d 119.23 ± 6.40*** d 95.94 ± 10.39*** c
GGT (U/l) 2.51 ± 0.36 6.06 ± 0.23*** 3.35 ± 0.12* a 5.48 ± 0.33*** d 4.9 ± 0.36** c 5.5 ± 0.25*** c 4.48 ± 0.24** b
Glucose (mg/dl) 53.53 ± 1.28 80.38 ± 1.55*** 55.23 ± 3.48NS a 76.40 ± 4.71** d 63.39 ± 1.42*** a 74.96 ± 2.95*** c 65.86 ± 3.43** b
Protein (g/dl) 4.77 ± 0.29 3.10 ± 0.23** 4.94 ± 0.05NS a 3.29 ± 0.21** d 4.19 ± 0.24NS b 3.62 ± 0.13** c 3.88 ± 0.07** b
Albumin (g/dl) 3.18 ± 0.07 1.42 ± 0.13*** 2.86 ± 0.17* a 1.53 ± 0.27*** d 1.96 ± 0.22*** a 1.55 ± 0.09*** NS 1.71 ± 0.26*** NS
Globulin (g/dl) 1.59 ± 0.30 1.68 ± 0.12NS 2.11 ± 0.17NS c 1.76 ± 0.28NS d 2.23 ± 0.03* b 2.06 ± 0.12NS c 2.17 ± 0.20NS c
Bilirubin (mg/dl) 0.41 ± 0.03 1.15 ± 0.04*** 0.51 ± 0.02* a 1.01 ± 0.03*** b 0.91 ± 0.06*** b 1.11 ± 0.07*** d 1.01 ± 0.02*** b
Urea (mg/dl) 20.58 ± 2.39 111.84 ± 3.54*** 35.25 ± 6.78* a 106.83 ± 3.23*** d 75.67 ± 5.59*** a 89.96 ± 3.77*** b 67.71 ± 7.43*** a
LDH (U/l) 219.16 ± 7.19 526.97 ± 7.97*** 288.44 ± 10.99*** a 511.31 ± 6.73*** d 433.8 ± 17.47*** b 495.13 ± 12.21*** c 472.24 ± 12.07*** b
Cholesterol
(mg/dl)
78.86 ± 3.49 134.52 ± 0.78*** 105.62 ± 3.36*** a 122.00 ± 5.39*** a 114.62 ± 5.39*** b 124.96 ± 5.38 *** d 113.48 ± 6.80** b
NSp = non-significant (p > 0.05), *p < 0.05, **p < 0.01 and ***p < 0.001 vs control
dp = non-significant (p > 0.05), cp < 0.05, bp < 0.01 and ap < 0.001 vs CCl4 group
Fig. 1 The effect of oleander extracts on the a Catalase and b Peroxidase activities in CCl4 intoxicated liver samples. Data represented as Mean ± SD of
six observations. *p < 0.05, **p < 0.01 and ***p < 0.001 Vs control group. δ = p > 0.05, γ = p < 0.05, β = p < 0.01 and α = p < 0.001 Vs CCl4 group
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leukocytes in the CCl4 group. Moreover, vascular conges-
tions and scattered regions of hepatic fibrosis marked the
intensive CCl4 mediated toxicity. The signs of hepatic
damage were also visible in the silymarin and extract
treated groups, however the extent of damage was much
lower than the CCl4 group. Liver samples of NOSE and
NORE high groups possessed much lover frequency of
necrotic nucleus, dilated sinusoids, infiltrated leukocytes,
deformed cellular architecture and vascular congestions.
This demonstrated amelioration of haloalkane induced
liver damage by the oleander extracts.
FTIR and GC-MS analysis
FTIR analysis of NOSE and NORE (Fig. 5) were per-
formed to identify the predominant chemical groups
present in the extracts. The IR spectrums displayed
different peaks (Additional file 3) at corresponding to
different functional groups [24].
Table 3 Changes in the levels of various enzymatic and biochemical parameters of the culture supernatants of the experimental
groups. Data represented as mean ± SD of six observations
Parameters (unit) Control CCl4 Silymarin NOSE low NOSE high NORE low NORE high
ACP (K.A.) 0.71 ± 0.10 1.74 ± 0.11*** 1.17 ± 0.16* b 1.58 ± 0.12*** d 1.48 ± 0.08*** c 1.61 ± 0.15** d 1.40 ± 0.16** c
ALP (K.A.) 3.09 ± 0.11 7.51 ± 0.33*** 4.13 ± 0.25** a 6.79 ± 0.24*** c 5.91 ± 0.27*** b 6.99 ± 0.37*** d 6.09 ± 0.50*** c
AST (U/ml) 14.87 ± 0.72 44.49 ± 0.75*** 16.39 ± 1.41NS a 43.86 ± 2.60*** d 36.32 ± 1.21*** a 38.06 ± 3.76*** c 29.53 ± 3.22** b
ALT (U/ml) 5.81 ± 0.15 27.55 ± 0.52*** 10.57 ± 0.29*** a 26.33 ± 1.29*** d 22.17 ± 2.40*** c 24.47 ± 1.82*** c 20.77 ± 1.63*** b
GGT (U/l) 0.59 ± 0.04 0.78 ± 0.02** 0.58 ± 0.01NS a 0.77 ± 0.01** d 0.71 ± 0.03* d 0.74 ± 0.00** d 0.72 ± 0.01** c
Bilirubin (mg/dl) 0.13 ± 0.00 0.53 ± 0.05*** 0.17 ± 0.00** a 0.56 ± 0.14** b 0.40 ± 0.02*** b 0.465 ± 0.02*** d 0.43 ± 0.02** d
Protein (g/dl) 6.48 ± 0.75 5.3 ± 0.26NS 5.7 ± 0.42 NS d 5.61 ± 0.23 NS d 6.05 ± 0.15 NS c 5.77 ± 0.12NS c 6.02 ± 0.21NS c
LDH (U/l) 35.94 ± 29.66 181.33 ± 11.24** 94.16 ± 7.34* a 138.59 ± 14.05** c 105.00 ± 10.02* a 144.40 ± 11.49** c 114.87 ± 10.53* b
NSp = non-significant (p > 0.05), *p < 0.05, **p < 0.01 and ***p < 0.001 vs control
dp = non-significant (p > 0.05), cp < 0.05, bp < 0.01 and ap < 0.001 vs CCl4 group
Fig. 2 The effects of oleander extract on a MDA level, b Cell viability, c TNF-α level and d NO release. Data represented as Mean ± SD of six
observations. *p < 0.05, **p < 0.01 and ***p < 0.001 Vs control group. δ = p > 0.05, γ = p < 0.05, β = p < 0.01 and α = p < 0.001 Vs CCl4 group
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NOSE and NORE were bi-fractionated and subjected
to GC-MS analysis. The analysis identified (Fig. 6 and
Additional file 4) several bioactive constituents in the
oleander extracts such as vanillin, trans- isoeugenol,
murrayafoline A, apocynin, squalene, β-amyrin, lupeol,
tocopherol etc.
Discussion
The toxicity profile of CCl4 has been thoroughly studied
and is well established [25–27]. CCl4 has a rich history
of environmental toxicity and occupational hazard due
to its extensive use in industrial sectors. This had led to
an awareness in the industrial and domestic use of CCl4
Fig. 3 Photomicrographs (100×) of the histopathological examinations of the liver samples of different groups. Even though the extract treated
groups possessed injury marks however, the extent of signs of injury were much lower in the extract treated groups compared to CCl4 group.
a Control group liver demonstrated normal liver architecture with normal sinusoids (NS), hepatocytes with intact nucleus (IN), un-inflamed portal
vein (PV). b CCl4 group liver demonstrated significant loss of hepatocellular architecture with extensive fatty infiltration (FI) leading to steatosis,
bile duct proliferation (BdP), vascular congestion (VC) and haemorrhagic necrosis (HN) around portal vein. Loss of hepatic nodular structure and
disorganized hepatocytes marked the CCl4 induced liver damage. c Silymarin group demonstrated hepatoprotective activity by substantial
amendment of proliferated bile duct (Bd) with normal sinusoids (NS) and intact portal veins (PV). d NOSE low group was marked by less leukocyte
infiltrations (LI), sinusoidal dilations (SD) and bile duct proliferation (BdP). e NOSE high group reflected comparatively less haemorrhagic necrosis
(HN) and fatty infiltrations (FI). f NORE low group also showed traces of sinusoidal dilations (SD), haemorrhagic necrosis (HN) and fatty infiltration
(FI). g NORE high group demonstrated lowering of most of the injury signs however, leukocyte infiltrations (LI) could be identified in the
liver samples
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from the early 70’s, leading to a ban on production and
import of CCl4 in 1996 [28]. However, CCl4 continues to
play an essential role as a model haloalkane xenobiotic
in the pharmaco-toxicological studies. CCl4 induced liver
damage is primarily initiated by the formation of tri-
chloromethyle radical (CCl3
●) due to cytochrome P450
mediated reductive dehalogenation of CCl4 [8, 29]. Per-
sistent formation of the highly reactive CCl3
● in the liver
cause steatosis, lipid peroxidation leading to hepatocarci-
noma [8]. Additionally, fusion of CCl3
● with diatomic
oxygen generates highly reactive trichloromethylperoxy
radical (CCl3OO
●) which further causes damage to mito-
chondria, endoplasmic reticulum and plasma membrane
permeability, resulting in loss of cytosolic Ca2+ seques-
tration and homeostasis [8]. The present study demon-
strated that, antioxidant rich oleander extracts hold the
Fig. 4 Photomicrographs (400×) of the histopathological examinations of the liver samples of different groups. a Control group liver sampled
possessed well packed hepatocytes with intact nucleus (IN) and normal sinusoids (NS). b CCl4 group liver possessed extensive fatty infiltrations
(FI), Necrotic hepatocytes (N), prominent signs of inflammation with leukocyte infiltrations (LI), prominent calcification (C) around the congested
vesicles (VC) with bile duct proliferations (BdP). c Silymarin group liver samples were characterized with normal sinusoids (NS) and intact nucleus
(IN) containing healthy hepatocytes. d NOSE low group demonstrated lower fatty infiltrations (FI), sinusoidal dilations (SD) and leukocyte
infiltrations (LI). e NOSE high group resulted in renewal of normal hepatic architecture with several hepatocytes with intact nucleus (IN) and
lowered sinusoidal dilations (SD). f NORE low group livers possessed few necrotic (N) cells, fatty infiltrations (FI) and zonal calcification (C) around
the portal veins (PV). g NOSE high group showed near to normal hepatic architecture with predominantly intact nucleus (IN) containing normal
hepatocytes and undiluted normal sinusoids (NS)
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potentiality to ameliorate CCl4 induced hepatotoxicity in
murine model. The data were further supported by the
identification of several phytochemical constituents with
well-established hepatoprotective potentialities.
CCl4 toxicity caused significant (p < 0.001) loss of body
weight as well as highest relative liver weight in the ani-
mals. Compared to control and silymarin group, the final
body weight change in the extract treated groups were
much less. This may presumably indicate the potentiality
of oleander extracts to restrict body weight increase
through anti-hyperlipidemic activity as demonstrated pre-
viously by body weight lowering capability of oleander
[30]. Compared to control, 1.80 fold higher relative liver
weight in the CCl4 group reflected formation of fatty liver
Fig. 5 Fourier transform infrared spectra of a NOSE and b NORE
Fig. 6 Gas chromatographic (GC) spectra of NOSE and NORE. a Dichloromethane fraction of NOSE, b N-hexane fraction of NOSE, c Dichloromethane
fraction of NORE and d N-hexane fraction of NORE. * represents repeat compound/unidentified compound/column component
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which was further supported by increased blood choles-
terol level and extensive steatosis throughout the CCl4 in-
toxicated liver samples. However, comparatively lower
relative liver weight associated with insignificant total
body weight change demonstrated the potentiality of ole-
ander extracts to prevent severe physiological conse-
quences due to CCl4 poisoning.
The altered levels of hepatobillary enzymes transamin-
ase and phosphatase along with other enzymatic and
biochemical parameters serve as biomarkers of hepato-
toxicity whereas, normalization of the parameters repre-
sents improvement of normal liver functions [31–33]. N.
indicum leaf extract has previously been shown to
normalize similar liver biomarkers under CCl4 toxicity
[14]. Moreover, oleander floral extracts normalized the
elevated AST, GGT, ALT, LDH, ALP and creatinine
levels in blood under isoproterenol-induced oxidative
stress in rats [34]. Furthermore, the anti-hyperlipidemic
activities were evident through lowering of cholesterol
levels and associated lowering of fatty infiltrations and
steatosis under the histopathological studies, which were
further supported by the previous studied of Gayathri
et al. [30]. The blood glucose level lowering capacity of
the oleander extracts is also supported by its ethnophar-
macological claim of hypoglycaemic activities as well as
a recent study that demonstrated anti-diabetic activities
of oleander leaf under alloxan induced diabetes in mouse
[35]. CCl4 toxicity in the present study, resulted in sig-
nificant (p < 0.001) elevation of ACP, ALP, AST, ALT,
GGT, LDH, glucose, urea, globulin, bilirubin and choles-
terol levels, signifying liver injury. Only the protein and
albumin levels were decreased compared to control. The
parameters were subsequently normalized up to certain
extent due to silymarin and oleander extract treatments.
Fig. 7 Schematic representation of the mode of action of oleander extracts to ameliorate CCl4 induced hepatotoxicity. Section (A) demonstrates
the mechanism of CCl4 induced hepatotoxicity which is predominantly mediated by oxidative stress and inflammatory injury due to the
formation of reactive metabolic intermediates. Cyt P450 = cytochrome P450, CCl3
● = trichloromethyle radical, CCl3OO
● = trichloromethylperoxy
radical, TNF-α = tumor necrosis factor-α, NO = nitric oxide. Section (B) represents the free radical formation cascade during xenobiotic induced
hepatotoxicity causing oxidative and nitrosative stress. CCl4 induced hepatic damage distorts normal liver architecture and leads to leakage of
liver marked enzymes into the blood stream. OH● = hydroxyl radical, O2
●− = superoxide radical, MPO =myeloperoxidase, ONOO− = peroxynitrite,
HOONO = peroxynitrous acid, NO2
● = nitrogen dioxide radical, 1O2 = singlet oxygen, H2O2 = hydrogen peroxide, SOD = Superoxide dismutase,
HOCl = hypochlorous acid
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Oleander extracts were further evaluated through
primary culture to ameliorate CCl4 induced toxicity in
mouse hepatocytes in vitro. Cultured liver cells are
biochemically prototypical to intact hepatic system and
therefore, serves as a model for evaluation of in vitro
hepatotoxicity [8]. The results of in vitro studies demon-
strated hepatoprotective potentialities of the extracts by
normalization of the liver enzymatic and biochemical pa-
rameters as well. Liver, in spite of having the highest re-
generative capacity, persistent exposure to cytochrome
P450 activated organic xenobiotics and their reactive
metabolic intermediates [36] cause tremendous hepato-
cellular necrosis. Necrotic hepatocytes with fragmented
nucleus and distorted cellular margins were clearly
evident through histopathological observations. Zonal
haemorrhagic necrosis around portal veins in the CCl4
group signified that the hepatocellular injury had
exceeded the regenerative power of the liver. This was
further confirmed through MTT cell viability assay
which showed 61.92 % loss of cell viability due to dir-
ect CCl4 exposure in the culture medium. However,
subsequent treatment with silymarin and oleander ex-
tracts prevented further hepatocellular damage result-
ing in significantly (p < 0.001) increase in viable cells
compared to CCl4 group.
Xenobiotic intoxicated liver encounters a plethora of
free radicals and reactive metabolic intermediates which
results in great damage to cellular components and the
extent of free radical medicated damage is proportional
to the extent of lipid peroxidation [37–39]. The resultant
oxidative stress further deactivates the cellular antioxida-
tive enzymes [40]. Peroxidase and catalase are two major
antioxidative enzymes responsible for the neutralization
of free radicals. Peroxidase reduces and converts hydro-
peroxides and lipid peroxides into non-reactive species,
whereas catalase prevents the formation of highly react-
ive OH● by scavenging H2O2 which participates in the
Fenton reaction. Inhibition of both enzymatic activities
accumulates O2
●− and H2O2 which accentuate a cascade
of free radical formation. CCl4 derived trichloromethyl-
peroxy radical (CCl3OO
●) abstracts proton from polyun-
saturated fatty acids in the biological membranes and
cause lipid peroxidation [8]. The reactive carbonyl
compound MDA is a biomarker for oxidative damage
and subsequent lipid peroxidation. The 70 % hydro-
methanolic extracts of oleander previously demonstrated
potent free radical scavenging activities by inhibiting some
of the most harmful free radicals such as OH●, O2
●−, NO,
ONOO−, H2O2 and
1O2 [11]. The study further showed
that oleander extracts hold the ability to prevent Fenton
reaction by means of neutralization of hydroperoxides and
also inhibit lipid peroxidation by scavenging OH● directly.
Lipid membranes are vulnerable to oxidative and nitrosa-
tive stress due to high amount of polyunsaturated fatty
acids and transition metals. Transition metals such as iron
are capable of damaging nuclear proteins, DNA, inhibit
enzymes and degrade lipid membrane through oxidative
Haber-Weiss reaction [41–43]. Our previous study
showed potent iron chelation ability by the oleander ex-
tracts [11]. Recent studies also showed that 70 % hydro-
methanolic extract of N. indicum leaf could ameliorate
hemochromatosis and fibrosis in liver due to its potent
antioxidant and iron chelation activities [13, 14]. Thus, the
present study corroborates the previous findings of the
antioxidative protection by oleander extracts. Lowering of
liver antioxidative enzymes due to CCl4 toxicity marked
increased oxidative stress, resulting in the elevation of
lipid peroxidation. However, the diminished catalase and
peroxidase levels and elevated MDA level were subse-
quently normalized by NOSE and NORE administration.
The present observations thus, remains in accordance
with the previous reports showing improvement of in-
house antioxidative enzymes by oleander leaf and flower
extracts under oxidative stress [34, 44].
Liver diseases are accompanied by inflammatory con-
ditions which accentuate the progression of liver failure.
TNF-α and NO play a major role as pro-inflammatory
mediators during CCl4 mediated liver injury which leads
towards apoptotic cell death and fibrosis [8, 45]. Under
such xenobiotic induced hepatotoxic conditions, acti-
vated Kupffer cells secret a vast array of cytokines (TNF-
α, IL-1, IL-8, IL-6), chemokines (KC/GRO, IP-109, MIP-
2, MCP-1) and pro-inflammatory mediators such as NO,
which initiate hepatic inflammation and induce toxicity
either by direct cellular damage or by chemoacttracting
neutrophils and lymphocytes [46]. TNF-α initiates hep-
atotoxicity and fibrogenesis and overproduction of NO
results in endotoxin shock and inflammatory hepatic in-
jury [45, 47, 48]. Inducible nitric oxide synthase (iNOS)
in liver parenchymal and non-parenchymal cells are in-
duced by TNF-α resulting in nitrosative stress. In liver
mitochondria, O2
●− couples with an excess of NO to
generate the highly reactive ONOO−. Interestingly, the
anti-inflammatory activity of oleander extract is well
known in traditional medicine and the extracts are also
used in the treatment of diverse inflammatory disorders
[17, 49]. In a preliminary study, Erdemoglu et al. [50]
demonstrated anti-inflammatory activities of ethanolic
and aqueous extracts of oleander leaves. Moreover, the
70 % hydro-methanolic extract of oleander leaves were
demonstrated to possess anti-inflammatory activities by
modulation of Th1/Th2 cytokine levels accompanied by
inhibition of NO, COX and PGE2 levels in concanavalin A
activated murine splenic lymphocytes [15, 16]. In the
present study, CCl4 toxicity resulted significant (p <
0.001) increase in TNF-α and NO levels, which were
subsequently lowered by the oleander extracts. This
exhibited potent anti-inflammatory activities of oleander
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extracts through suppression of pro-inflammatory media-
tors of chronic hepatotoxicity.
The hepatoprotective potentiality of oleander extracts
were further established through detailed histopatho-
logical studies. The results clearly demonstrated that
deformed hepatic architecture due to CCL4 toxicity was
subsequently attenuated by oleander extracts. CCl4 tox-
icity initiated tremendous hepatocellular degeneration as
evident by scattered hepatocellular necrosis and in some
cases with central haemorrhagic necrosis. Deformed nu-
cleus containing overlapping hepatocytes with irregular
cellular margins were characteristics of CCl4 group
which highly contrasted the prominent nucleus contain-
ing healthy hepatocytes with conspicuous cellular bound-
aries in the control. Loss of cellular integrity in the CCl4
group were visible in terms of disorganized arrangement
of the hepatocytes. Interestingly, liver samples of the
CCl4 group exhibited an extensive, yet typical signs of
inflammation by means of infiltration of leukocytes
from the portal regions extended towards the hepato-
cyte rich central zones, which were comparatively less
in the silymarin and extract treated groups. Extensive
fatty infiltration throughout the CCl4 group liver sam-
ples signified initiation of macrovascular steatosis and
adipose degeneration that were less in the NOSE and
NORE groups. Moreover, the deformity of the hepatic
nodules associated vascular congestions with occasional
bile duct proliferations were also lowered in the sily-
marin and extract treated groups. Overall, the deformed
hepatocellular architecture of the CCl4 group were sig-
nificantly normalized by oleander extracts.
NOSE and NORE were further analysed using FTIR
and GC-MS method to reveal the phytochemical constit-
uents responsible for the potent hepatoprotective poten-
tiality. Different functional groups were identified through
FTIR analysis, which correlating with the compounds
identified in the GC-MS study. Alkanes like tetradecane
and hexadecane resulted in = C-H bending. The C-O
stretching of carboxylic moiety resulted due to the pres-
ence of linoleic acid, n-hexadecanoic acid, benzoic acid,
eicosenoic acid, oleic acid etc. The O-H stretching of the
alcohol/phenolic species were supported by the presence
of lupeol, amyrin, isoeugenol, vanillin and other phenolic
phytochemicals. In GC-MS analysis, both the fractions of
the extracts revealed the presence of several bioactive con-
stituents which corroborates a previous report of a prelim-
inary phytochemical analysis of oleander [51]. The 70 %
hydro-methanolic extracts of oleander leaf, steam and
root possessed high amount of phenolic and flavonoid
contents, contributing to its antioxidant and free rad-
ical scavenging activities [11]. A detailed account of
related bioactivities of individual phytocompounds are
enlisted in Additional file 5, which supports the view
that the hepatoprotective activity of oleander extract
resulted due to additive and synergistic activities of the
component phytochemicals.
Conclusion
The present study demonstrated that oleander stem and
root extracts attenuated reactive species mediated liver
damage which was evident through significant lowering
of lipid peroxidation and elevation of antioxidant enzym-
atic activities. Normalization of the liver enzymatic and
biochemical markers under both in vivo and in vitro liver
function tests provided convincing evidence of the hepato-
protective potentialities of the oleander extracts. Histo-
pathological studies provided confirmative visual support
towards the improvement of hepatic architecture as well.
Therefore, it may be concluded that oleander extracts
ameliorated CCl4 induced liver injury primarily through
normalization of liver antioxidant enzymes and inhib-
ition of pro-inflammatory signals. The hepatoprotective
activities may be attributed to the presence of bioactive
constituents in the extracts. The mode of hepatoprotec-
tive activity of oleander may thus, be represented as
Fig. 7. Our future endeavour will be isolation and
characterization of major bioactive species and detailed
study of their physiological implications.
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